Skip to main content

Table 3 The proportion of patients who were dispensed benzodiazepines, z-hypnotics, and gabapentinoids, respectively

From: Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017

Year20132014201520162017
Benzodiazepines or z-hypnoticsNo.%aNo.%aNo.%aNo.%aNo.%a
 Oxazepam209428209127212427218328222929
 Diazepam121616125116122216127217128917
 Zopiclone10261496412932129361286311
 Nitrazepam757107591074710737107019
 Clonazepam47964326362533142684
 Zolpidem35153595333431543274
 Alprazolam30543044237320631963
 Flunitrazepam411380370320360
GabapentinoidsNo.%aNo.%aNo.%aNo.%aNo.%a
 Pregabalin48764496491652375918
 Gabapentin26032403277429143104
  1. No. Number of patients, OAT Opioid agonist therapy
  2. aPercent of all patients who were dispensed an OAT opioid
  3. The table displays the proportion of all OAT patients who were dispensed different benzodiazepines, z-hypnotics, and gabapentinoids